Cochrane Review Group
Pregnancy and Childbirth
252 systematic reviews in Pregnancy and Childbirth ask 3,601 questions. 20.2% have no studies to answer them, 23% rest on very low certainty evidence and 17.6% reach moderate or high certainty.
Reviews
252
Questions
3,601
current versions
No studies
20.2%
Moderate or high
17.6%
No studies 726 · 20.2%Ungraded 421 · 11.7%Very low 828 · 23%Low 993 · 27.6%Moderate 486 · 13.5%High 147 · 4.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Magnesium sulphate vs placebo (outcomes Major neurodevelopmental disability (school age)** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | RR 0.92 [0.53, 1.62] | 2 studies · 940 participants | Very low |
Magnesium sulphate vs placebo (outcomes Breastfeeding at hospital discharge** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulphate vs placebo (outcomes Women’s views of treatment** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Midwife continuity models vs other models of care Third or fourth degree tear · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.1 [0.81, 1.49] | 7 studies · 9437 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Maternal readmission within 28 days · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.52 [0.78, 2.96] | 1 study · 1195 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Attendance at birth by known midwife · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 9.13 [5.87, 14.21] | 11 studies · 9273 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Apgar score less than or equal to 7 at 5 minutes · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.95 [0.72, 1.24] | 13 studies · 12806 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Fetal loss before 24 weeks gestation · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.82 [0.67, 1.01] | 12 studies · 15913 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Regional analgesia (epidural/spinal) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.79, 0.92] | 15 studies · 17754 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Fetal loss at or after 24 weeks gestation · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.24 [0.73, 2.13] | 12 studies · 16122 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Neonatal death (baby born alive at any gestation and dies within 28 days) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.43, 1.71] | 10 studies · 14718 participants | Very low |
Summary of findings table ‐ Vitamin B12 supplementation vs placebo/no vitamin B12 supplementation Maternal anaemia · pregnant women Vitamin B12 supplementation during pregnancy for maternal and child health outcomes (2024) · Cochrane | RR 1.08 [0.93, 1.26] | 2 studies · 284 participants | Very low |
Reviews 252
Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes
CochraneSoF table
6 questions
Prenatal education for congenital toxoplasmosis
CochraneSoF table
6 questions
Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery
CochraneSoF table
3 questions
Planned caesarean section for women with a twin pregnancy
CochraneSoF table
7 questions
Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes
CochraneSoF table
6 questions
Ultrasound for fetal assessment in early pregnancy
CochraneSoF table
4 questions
Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
CochraneSoF table
3 questions
Diet or exercise, or both, for preventing excessive weight gain in pregnancy
CochraneSoF table
7 questions
High feedback versus low feedback of prenatal ultrasound for reducing maternal anxiety and improving maternal health behaviour in pregnancy
CochraneSoF table
5 questions
Group versus conventional antenatal care for women
CochraneSoF table
7 questions
Antenatal cardiotocography for fetal assessment
CochraneSoF table
14 questions
Tranexamic acid for preventing postpartum haemorrhage
CochraneSoF table
7 questions
Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development
CochraneSoF table
6 questions
Effects and safety of periconceptional oral folate supplementation for preventing birth defects
CochraneSoF table
10 questions
Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth
CochraneSoF table
7 questions
Vitamin A supplementation during pregnancy for maternal and newborn outcomes
CochraneSoF table
10 questions
Interventions for preventing recurrent urinary tract infection during pregnancy
CochraneSoF table
7 questions
Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes
CochraneSoF table
7 questions
Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes
CochraneSoF table
7 questions
Intermittent oral iron supplementation during pregnancy
CochraneSoF table
12 questions
Treatments for breast abscesses in breastfeeding women
CochraneSoF table
3 questions
Methods for assessing pre‐induction cervical ripening
CochraneSoF table
7 questions
Treatment for women with postpartum iron deficiency anaemia
CochraneSoF table
42 questions
Health system and community level interventions for improving antenatal care coverage and health outcomes
CochraneSoF table
14 questions
Multiple micronutrient powders for home (point‐of‐use) fortification of foods in pregnant women
CochraneSoF table
12 questions